Association of Long‐term Change in Waist Circumference With Insulin Resistance
暂无分享,去创建一个
D. Jacobs | J. Shikany | D. Erickson | J. Himes | D. Lee | Kyong Park
[1] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[2] D. Jacobs,et al. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002 , 2007, Diabetologia.
[3] D. Jacobs,et al. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2007, The American journal of clinical nutrition.
[4] S. Gravas. Epidemiologic trends indicate the prevalence of obesity will rise globally. , 2007, European urology.
[5] D. Jacobs,et al. Association Between Serum Concentrations of Persistent Organic Pollutants and Insulin Resistance Among Nondiabetic Adults , 2007, Diabetes Care.
[6] Liviu Klein,et al. Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study , 2007, Circulation.
[7] D. Jacobs,et al. Could low-level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes? , 2006, Journal of Epidemiology and Community Health.
[8] D. Jacobs,et al. A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes , 2006, Diabetes Care.
[9] Shinji Kihara,et al. Adiponectin: a key adipocytokine in metabolic syndrome. , 2006, Clinical science.
[10] M. Schulze,et al. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2006, The American journal of clinical nutrition.
[11] R. Paffenbarger,et al. Weight change and risk of developing type 2 diabetes. , 2005, Obesity research.
[12] S. Wannamethee,et al. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes , 2005, Journal of Epidemiology and Community Health.
[13] J. Connell,et al. The role of insulin and the adipocytokines in regulation of vascular endothelial function. , 2004, Clinical science.
[14] Marjolein Visser,et al. Re: "Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men". , 2004, American journal of epidemiology.
[15] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[16] Donna Spiegelman,et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. , 2004, American journal of epidemiology.
[17] H. Lebovitz. The relationship of obesity to the metabolic syndrome. , 2003, International journal of clinical practice. Supplement.
[18] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[19] K. Frayn,et al. Adipose tissue as a buffer for daily lipid flux , 2002, Diabetologia.
[20] S. O’Rahilly,et al. Metabolism: Partial leptin deficiency and human adiposity , 2001, Nature.
[21] Bruce M. Spiegelman,et al. Obesity and the Regulation of Energy Balance , 2001, Cell.
[22] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[23] A. Tremblay,et al. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals , 2000, International Journal of Obesity.
[24] J. Flier,et al. Obesity and insulin resistance. , 2000, The Journal of clinical investigation.
[25] J. Halter,et al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults , 2000, Journal of epidemiology and community health.
[26] S. O’Rahilly,et al. The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.
[27] B. Fisher. Most unwanted. , 1999, Environmental health perspectives.
[28] J. Halaas,et al. Leptin and the regulation of body weight in mammals , 1998, Nature.
[29] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[30] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[31] D. Williamson,et al. Weight change and diabetes incidence: findings from a national cohort of US adults. , 1997, American journal of epidemiology.
[32] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[33] S. Haffner,et al. Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans , 1995, Diabetes.
[34] G. Colditz,et al. Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women , 1995, Annals of Internal Medicine.
[35] K. Narayan,et al. Rate of Weight Gain, Weight Fluctuation, and Incidence of NIDDM , 1995, Diabetes.
[36] E. Ravussin,et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.
[37] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[38] R. N. Bergman,et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.
[39] H. Lithell,et al. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. , 1991, BMJ.
[40] A. Fontbonne,et al. Risk Factors for NIDDM in White Population: Paris Prospective Study , 1991, Diabetes.